loadpatents
name:-0.032039165496826
name:-0.012938022613525
name:-0.00060701370239258
Convard; Thierry Patent Filings

Convard; Thierry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Convard; Thierry.The latest application filed is for "macrocyclic serine protease inhibitors".

Company Profile
0.15.14
  • Convard; Thierry - Sathonay-Camp FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
Grant 9,353,100 - Parsy , et al. May 31, 2
2016-05-31
Macrocyclic serine protease inhibitors
Grant 9,284,307 - Parsy , et al. March 15, 2
2016-03-15
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
Grant 9,187,496 - Dousson , et al. November 17, 2
2015-11-17
Macrocyclic serine protease inhibitors
Grant 8,993,595 - Parsy , et al. March 31, 2
2015-03-31
Macrocyclic Serine Protease Inhibitors
App 20130224147 - Parsy; Christophe Claude ;   et al.
2013-08-29
Novel Specific Caspase-10 Inhibitors
App 20130090385 - LARDY; Claude ;   et al.
2013-04-11
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors
App 20130071352 - Dousson; Cyril B. ;   et al.
2013-03-21
Macrocyclic serine protease inhibitors
Grant 8,377,962 - Parsy , et al. February 19, 2
2013-02-19
5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
Grant 8,362,068 - Dousson , et al. January 29, 2
2013-01-29
Specific caspase-10 inhibitors
Grant 8,357,721 - Lardy , et al. January 22, 2
2013-01-22
Methods For Treating Drug-resistant Hepatitis C Virus Infection With A 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitor
App 20120252721 - Dousson; Cyril B. ;   et al.
2012-10-04
Macrocyclic Serine Protease Inhibitors, Pharmaceutical Compositions Thereof, And Their Use For Treating Hcv Infections
App 20120207703 - PARSY; Christophe Claude ;   et al.
2012-08-16
5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors
App 20110150827 - Dousson; Cyril B. ;   et al.
2011-06-23
Macrocyclic Serine Protease Inhibitors
App 20110129443 - Parsy; Christophe Claude ;   et al.
2011-06-02
Specific caspase-10 inhibitors
Grant 7,829,721 - Lardy , et al. November 9, 2
2010-11-09
Macrocyclic Serine Protease Inhibitors
App 20100260710 - Parsy; Christophe Claude ;   et al.
2010-10-14
Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer protein
Grant 7,767,819 - Guedat , et al. August 3, 2
2010-08-03
Thiazolylimidazole Derivatives An Their Use As Inhibitors Of Microsomal Triglyceride Transfer Protein
App 20100137601 - GUEDAT; Philippe ;   et al.
2010-06-03
Novel Specific Caspase-10 Inhibitors
App 20080255173 - Lardy; Claude ;   et al.
2008-10-16
Thiazolylimidazole Derivatives and Their Use as Inhibitors of Microsmal Triglyceride Transfer Protein
App 20080214610 - Guedat; Philippe ;   et al.
2008-09-04
Novel Specific Caspase-10 Inhibitors
App 20080182906 - Lardy; Claude ;   et al.
2008-07-31
Seven-membered ring nucleosides
App 20070185063 - Storer; Richard ;   et al.
2007-08-09
Computational data processing system and computational process implemented by means of such a system
Grant 7,159,012 - Viollet , et al. January 2, 2
2007-01-02
Computational data processing system and computational process implemented by means of such a system
App 20010023434 - Viollet, Edouard ;   et al.
2001-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed